Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by JOHN E MADEWELL and COLLEEN COSTELLOE.
JOHN E MADEWELL
Connection Strength
9.763
COLLEEN COSTELLOE
  1. An Approach to Undiagnosed Bone Tumors. Semin Ultrasound CT MR. 2021 Apr; 42(2):114-122.
    View in: PubMed
    Score: 0.748
  2. Bone Metastases: Mechanisms of the Metastatic Process, Imaging and Therapy. Semin Ultrasound CT MR. 2021 Apr; 42(2):164-183.
    View in: PubMed
    Score: 0.748
  3. Erratum to "Risks and Benefits of Gadolinium-Based Contrast Enhanced MRI" [SEMIN ULTRASOUND CT 41/2 (2020) 260-274]. Semin Ultrasound CT MR. 2020 Apr; 41(2):R1.
    View in: PubMed
    Score: 0.727
  4. WITHDRAWN: Risks and Benefits of Gadolinium-Based Contrast Enhanced MRI. Semin Ultrasound CT MR. 2020 04; 41(2):260-274.
    View in: PubMed
    Score: 0.723
  5. Risks and Benefits of Gadolinium-Based Contrast-Enhanced MRI. Semin Ultrasound CT MR. 2020 Apr; 41(2):170-182.
    View in: PubMed
    Score: 0.711
  6. FDG PET/CT of primary bone tumors. AJR Am J Roentgenol. 2014 Jun; 202(6):W521-31.
    View in: PubMed
    Score: 0.485
  7. Reply: To PMID 23255735. AJR Am J Roentgenol. 2013 Nov; 201(5):W771.
    View in: PubMed
    Score: 0.466
  8. Bone Windows for Distinguishing Malignant from Benign Primary Bone Tumors on FDG PET/CT. J Cancer. 2013; 4(7):524-30.
    View in: PubMed
    Score: 0.459
  9. Radiography in the initial diagnosis of primary bone tumors. AJR Am J Roentgenol. 2013 Jan; 200(1):3-7.
    View in: PubMed
    Score: 0.440
  10. Fast Dixon whole-body MRI for detecting distant cancer metastasis: a preliminary clinical study. J Magn Reson Imaging. 2012 Feb; 35(2):399-408.
    View in: PubMed
    Score: 0.404
  11. Comparison of half-dose and full-dose gadolinium MR contrast on the enhancement of bone and soft tissue tumors. Skeletal Radiol. 2011 Mar; 40(3):327-33.
    View in: PubMed
    Score: 0.376
  12. FDG PET for the Detection of Bone Metastases: Sensitivity, Specificity and Comparison with Other Imaging Modalities. PET Clin. 2010 Jul; 5(3):281-95.
    View in: PubMed
    Score: 0.372
  13. Imaging chronic sclerosing osteitis of the diaphysis of tubular bones. AJR Am J Roentgenol. 2009 Mar; 192(3):736-42.
    View in: PubMed
    Score: 0.337
  14. Imaging characteristics of locally recurrent tumors of bone. AJR Am J Roentgenol. 2007 Mar; 188(3):855-63.
    View in: PubMed
    Score: 0.293
  15. Perfusion-weighted imaging with dynamic contrast enhancement (PWI/DCE) morphologic, qualitative, semiquantitative, and radiomics features predicting undifferentiated pleomorphic sarcoma (UPS) treatment response. Sci Rep. 2024 09 17; 14(1):21681.
    View in: PubMed
    Score: 0.248
  16. Advanced Imaging in Musculoskeletal Oncology: Moving Away From RECIST and Embracing Advanced Bone and Soft Tissue Tumor Imaging (ABASTI) - Part I - Tumor Response Criteria and Established Functional Imaging Techniques. Semin Ultrasound CT MR. 2021 Apr; 42(2):201-214.
    View in: PubMed
    Score: 0.187
  17. Advanced Imaging in Musculoskeletal Oncology: Moving Away From RECIST and Embracing Advanced Bone and Soft Tissue Tumor Imaging (ABASTI)-Part II-Novel Functional Imaging Techniques. Semin Ultrasound CT MR. 2021 Apr; 42(2):215-227.
    View in: PubMed
    Score: 0.187
  18. Gadolinium-based Contrast Agents Improve Detection of Recurrent Soft-Tissue Sarcoma at MRI. Radiol Imaging Cancer. 2020 03; 2(2):e190046.
    View in: PubMed
    Score: 0.182
  19. VIDEO: Preoperative CT Angiography for Scapula Osteocutaneous Free Flap Reconstructions. AJR Am J Roentgenol. 2019 09; 213(3):W143-W144.
    View in: PubMed
    Score: 0.172
  20. VIDEO: Preoperative CT Angiography for Fibular Free Flap Reconstructions. AJR Am J Roentgenol. 2018 Jun; 210(6):W264.
    View in: PubMed
    Score: 0.159
  21. 18F-FDG PET/CT as an Indicator of Survival in Ewing Sarcoma of Bone. J Cancer. 2017; 8(15):2892-2898.
    View in: PubMed
    Score: 0.152
  22. VIDEO: Preoperative CT Angiography for Anterolateral Thigh Flap Reconstructions. AJR Am J Roentgenol. 2017 Mar; 208(3):W127.
    View in: PubMed
    Score: 0.145
  23. Differentiation of Benign Fluid Collections from Soft-Tissue Sarcomas on FDG-PET/CT. J Cancer. 2014; 5(5):328-35.
    View in: PubMed
    Score: 0.120
  24. Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: clinical utility per sequence. Magn Reson Imaging. 2013 Jun; 31(5):669-75.
    View in: PubMed
    Score: 0.110
  25. Skeletal muscle metastases: a three-part study of a not-so-rare entity. Skeletal Radiol. 2012 Aug; 41(8):899-909.
    View in: PubMed
    Score: 0.102
  26. Comparison of gadolinium-enhanced fat-saturated T1-weighted FLAIR and fast spin-echo MRI of the spine at 3 T for evaluation of extradural lesions. AJR Am J Roentgenol. 2011 Sep; 197(3):697-703.
    View in: PubMed
    Score: 0.100
  27. Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST. J Cancer. 2010 Jun 28; 1:80-92.
    View in: PubMed
    Score: 0.092
  28. Tumor necrosis in osteosarcoma: inclusion of the point of greatest metabolic activity from F-18 FDG PET/CT in the histopathologic analysis. Skeletal Radiol. 2010 Feb; 39(2):131-40.
    View in: PubMed
    Score: 0.088
  29. Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol. 2009 Jun; 10(6):606-14.
    View in: PubMed
    Score: 0.086
  30. 18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma. J Nucl Med. 2009 Mar; 50(3):340-7.
    View in: PubMed
    Score: 0.084
  31. Cancer Radiomic and Perfusion Imaging Automated Framework: Validation on Musculoskeletal Tumors. JCO Clin Cancer Inform. 2024 01; 8:e2300118.
    View in: PubMed
    Score: 0.059
  32. The lumbar artery perforator flap: clinical review and guidance on image reporting. Clin Radiol. 2019 Oct; 74(10):756-762.
    View in: PubMed
    Score: 0.043
  33. A prospective study of bone tumor response assessment in metastatic breast cancer. Clin Breast Cancer. 2013 Feb; 13(1):24-30.
    View in: PubMed
    Score: 0.027
  34. FDG-PET/CT compared with conventional imaging in the detection of distant metastases of primary breast cancer. Oncologist. 2011; 16(8):1111-9.
    View in: PubMed
    Score: 0.025
  35. Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer. Oncologist. 2011; 16(6):772-82.
    View in: PubMed
    Score: 0.025
  36. Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer. Br J Cancer. 2010 Feb 16; 102(4):651-7.
    View in: PubMed
    Score: 0.022
  37. Fast dixon-based multisequence and multiplanar MRI for whole-body detection of cancer metastases. J Magn Reson Imaging. 2009 May; 29(5):1154-62.
    View in: PubMed
    Score: 0.021
  38. Use of vascularized periosteum or bone to improve healing of segmental allografts after tumor resection: an ovine rib model. Plast Reconstr Surg. 2009 Jan; 123(1):71-78.
    View in: PubMed
    Score: 0.021
  39. Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma. Cancer. 2007 Feb 01; 109(3):603-11.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.